Advocate
Bioethics paper: industry "buries" unfavorable studies
Submitted by Anonymous on Mon, 2010-02-08 11:23The always outstanding Carlat blog has a nice item this morning about the lengths pharmaceutical companies will go to in order to bury unfavorable results.
I used to enjoy playing "Devil's Advocate" with the drug reps, arguing points with them. I now realize that, as they say, the reps are always the last to know, and they just will say what they have been trained to say. Then they get laid off. It must be a tough job.
- Read more
- 158 reads
NYT weighs in on trend towards consolidation therapy and it's not exactly pleased
Submitted by Anonymous on Mon, 2009-07-20 23:19Andrew Pollack is probably the single most influential health writer in America. He has the bully pulpit the closest thing to a national platform. His reporting is excellent balanced and thorough. I had the privilege of speaking with him in April 2009 for a tamoxifen article though he did not quote me in the story. So it was somewhat provocative that Mr. Pollack seems not altogether happy about the trend towards maintenance therapy. Higher costs longer treatment.
- Read more
- 29 reads
Announcing Patient Advocate Foundation's Annual Patient Congress
Submitted by Anonymous on Mon, 2009-04-06 08:51- 1-800-532-5274
- Advocate
- Anne Reed
- Congress
- DC
- Fran Castellow
- Fran Castellow Patient Congress Headquarters Hotel Washington Court Hotel
- Geography
- Health
- Health
- healthcare
- Labor
- Labor
- Medical ethics
- Patient advocacy
- Political geography
- Social Issues
- Social Issues
- United States Capitol
- USD
- Washington
- Washington DC
- Washington, D.C.
Patient Advocate Foundation’s 10th Annual Patient Congress June 24-25 2009 Washington DC Join us and EDUCATE yourself on healthcare topics EMPOWER yourself to take control of your own healthcare and encourage yourself to ENACT this education and empowerment to make a difference in the nation's healthcare system.
- Read more
- 36 reads
Thyroid cancer: a review
Submitted by Anonymous on Tue, 2009-01-20 18:59- Advocate
- Anaplastic thyroid cancer
- author
- Cancer Treatment
- chemotherapy
- energy
- Follicular thyroid cancer
- Goitre
- Graves' disease
- http://www.cancer.gov/cancertopics/types/thyroid
- http://www.cancer.org/docroot/CRI/content/CRI_2_4_1X_What_is_thyroid_can...
- Hyperthyroidism
- imaging
- Medicine
- Medullary thyroid cancer
- MRI
- National Cancer Institute
- Oncology
- Otolaryngology
- PET
- physician
- radiation
- RAI
- Social Issues
- Social Issues
- surgeon
- surgeon for best results
- Thyroid disease
- Thyroid neoplasm
- Thyroidectomy
- treatment of thyroid cancer
- treatment of thyroid lymphoma
- ultrasound
- United States
Where is the thyroid gland and what is it’s function? The thyroid gland is shaped like a butterfly and sits just below the voice box and in front of the trachea (wind-pipe). It resides under thin muscle layers in the midline central neck just above the sternum and moves with swallowing as it is attached to the trachea. The thyroid gland is a central organ in the body that secretes thyroid hormones and as such regulates our body’s metabolism energy level and various other functions.
- Read more
- 217 reads
BPA may reduce chemo effectiveness
Submitted by Anonymous on Wed, 2008-12-31 11:41- Advocate
- Baby bottle
- Bisphenol A
- Breast cancer
- Cancer
- chemical
- Chemotherapy
- chemotherapy
- Department of Health and Human Services
- Dielectrics
- Estrogen
- food
- Food and Drug Administration
- Medicine
- Phenols
- Plastic
- Plasticizers
- Risk factors of breast cancer
- Technology
- Technology
- University of Cincinnati
- University of Cincinnati
Bisphenol A (BPA) is an industrial chemical typically used in making plastic stronger. It is also utilized in sealing food cans baby bottles water bottles some food containers CDs and dental sealants and prevents liquid leaking out of bottles. It actually persuades a group of proteins that defend cancer cells from the toxic effects of chemotherapy. BPA falls under the “some concern” categories. BPA has been in the news recently because of its probable health vulnerability.
- Read more
- 48 reads
Leukemia drug shows activity--for MS!
Submitted by Anonymous on Tue, 2008-12-30 20:24- Advocate
- Alemtuzumab
- Autoimmune diseases
- Biology
- Clinical Neurosciences University of Cambridge
- Cytokines
- Immune system
- Interferon
- Interferon beta-1a
- lecturer
- Medicine
- Monoclonal antibodies
- Multiple sclerosis
- Neurological disorders
- New England Journal
- Other
- the New England Journal of Medicine
- treatment of MS
- Treatment of multiple sclerosis
- United States
Multiple sclerosis (MS) is the most common neurological disorder which affects the brain and spinal cord of generally young persons. Majority of researchers consider it as an "autoimmune disease” in which white blood cells intend to fight infection or disease are mistaken to target and attack the body's own cells. MS affects almost 400 000 people in the United States and quite a few million worldwide. Many useful medications are available for the treatment of MS.
- Read more
- 59 reads
Updated data: 17% mortality risk from ESAs in cancer patients
Submitted by Anonymous on Fri, 2008-12-26 19:55- Advocate
- American Society
- Amgen
- Andreas Engert
- Anemia
- author
- Blood disorders
- Boston
- Cancer
- chemotherapy
- Children's Hospital
- Continuous erythropoietin receptor activator
- dialysis
- Erythropoiesis-stimulating agents
- Erythropoietin
- ESA
- FDA
- Growth factors
- Julia Bohlius
- Leonard Zon
- Medicine
- Person Career
- Quotation
- researcher
- Silver
- spokesman
- Switzerland
- Technology
- Technology
- University of Bern
- University of Cologne Germany
A large meta-analysis of cancer patients who are taking erythropoietin-stimulating agents (ESAs) has established that there is a considerable increased risk of death related with these agents. While the outcome is not new but it has led to restriction labeling and black box warnings for these products and it will inculcate apprehension over the use of ESAs in cancer patients say experts. These findings are the outcome of a detailed study carried out on 13 933 cancer patients from 53 clinical trials.
- Read more
- 58 reads
Study questions use of probiotics for eczema
Submitted by Anonymous on Fri, 2008-10-17 07:15A report undertaken at the Cochrane Library has found that no evidence exists for the alleviation of Eczema by probiotics but that some data points towards a correlation with infections and gut problems. The results of this research coincide with the current and increasing trend of probiotic bacteria being used to treat Eczema. Affecting 5% of people at some juncture in their lives Eczema is a condition characterised by itchy skin and is particularly common in children.
- Read more
- 64 reads
